Impact of <scp>DLL3</scp> Expression as Prognostic Factor in Extensive Stage of Small Cell Lung Cancer Treated With First‐Line Chemotherapy
DLL3 was highly expressed in SCLC, and not associated with any clinico-pathological characteristics. In survival outcome, DLL3 was correlated with worse OS, which suggests the prognostic role of DLL3 in ES-SCLC.
Authors
- Soon‐Hee Jung (ORCID: https://orcid.org/0000-0003-3565-3426)
- Jee Hyun Kong (ORCID: https://orcid.org/0000-0001-7833-8480)
- Jii Bum Lee (ORCID: https://orcid.org/0000-0001-5608-3157)
- Hohyung Nam
- Seungtaek Lim (ORCID: https://orcid.org/0000-0001-7258-2263)
Institutions
- Yonsei University (KR)
- Wonju Severance Christian Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1111/1759-7714.15522
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00